References
- Wolfe F, Clauw DJ, Fitzcharles MA, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol 2011;38:1113–22
- Hudson JI, Goldenberg DL, Pope HG, et al. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 1992;92:363–7
- Bellato E, Marini E, Castoldi F, et al. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat 2012;2012:426130
- Crofford LJ, Young EA, Engleberg NC, et al. Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain Behav Immun 2004;18:314–25
- Neumann L, Buskila D. Epidemiology of fibromyalgia. Curr Pain Headache Rep 2003;7:362–8
- Østensen M, Rugelsjoen A, Wigers SH. The effect of reproductive events and alterations of sex hormone levels on the symptoms of fibromyalgia. Scand J Rheumatol 1997;26:355–60
- Zioni T, Buskila D, Aricha-Tamir B, et al. Pregnancy outcome in patients with fibromyalgia syndrome. J Matern Fet Med 2001;24:1325–8
- Saa’d S, Many A, Jacob G, Ablin JN. High prevalence of fibromyalgia symptoms among healthy full-term pregnant women. Rheumatol Int 2013;33:1555–60
- Leach LS, Christensen H, Mackinnon A. Pregnancy and levels of depression and anxiety: a prospective cohort study of Australian women. Aust N Z J Psychiatry 2014; 0004867414533013
- Buckwalter JG, Stanczyk FZ, McCleary CA, et al. Pregnancy, the postpartum, and steroid hormones: effects on cognition and mood. Psychoneuroendocrinology 1999;24:69–84
- Gur A, Cevik R, Sarac AJ, et al. Hypothalamic-pituitary-gonadal axis and cortisol in young women with primary fibromyalgia: the potential roles of depression, fatigue, and sleep disturbance in the occurrence of hypocortisolism. Ann Rheum Dis 2004;63:1504–6
- Fischler B, Dendale P, Michiels V, et al. Physical fatigability and exercise capacity in chronic fatigue syndrome: association with disability, somatization and psychopathology. J Psychosom R 1997;42:369–78
- Young SN. How to increase serotonin in the human brain without drugs. J Psychiatry Neurosci JPN 2007;32:394
- Takikawa O. Biochemical and medical aspects of the indolamine 2, 3-dioxygenase-initiated L-tryptophan metabolism. Biochem Biophys Res Commun 2005;338:12–9
- Cools R, Roberts AC, Robbins TW. Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn Sci (Regul Ed) 2008;12:31–40
- Russell IJ. Neurohormonal aspects of fibromyalgia syndrome. Rheum Dis Clin North Am 1989;15:149–68
- Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med 2009;60:355–66
- Walitt B, Urrútia G, Nishishinya MB, et al. Selective serotonin reuptake inhibitors for fibromyalgia syndrome. Cochrane Database Syst Rev 2015;(6):CD011735
- Fuchs D, Schrocksnadel H, Baier-Bitterlich G, et al. Activated cellular immunity and decreased serum tryptophan in healthy pregnancy. Adv Exp Med Biol 1996;398:149–53
- Bailara KM, Henry C, Lestage J, et al. Decreased brain tryptophan availability as a partial determinant of post-partum blues. Psychoneuroendocrino 2006;31:407–13
- Doornbos B, Hormones, monoamines and peripartum affective symptoms. Groningen: University Library Groningen; 2009
- Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010;62:600–10
- Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol 1991;18:728–34
- Sarmer S, Ergin S, Yavuzer G. The validity and reliability of the Turkish version of the Fibromyalgia impact questionnaire. Rheumatol Int 2000;20:9–12
- Beck AT, Steer RA, Garbin GM. Psychometric properties of the Beck depression inventory: twenty-five years of evaluation. Clin Psychol Rev 1988;8:77–100
- Taylor SS, Davis MC, Zautra AJ. Relationship status and quality moderate daily pain-related changes in physical disability, affect, and cognitions in women with chronic pain. Pain 2013;154:147–53
- Raftery MN, Sarma K, Murphy AW, et al. Chronic pain in the Republic of Ireland—community prevalence, psychosocial profile and predictors of pain-related disability: results from the Prevalence, Impact and Cost of Chronic Pain (PRIME) study, part 1. Pain 2011;152:1096–103
- Smith MT, Haythornthwaite JA. How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Med Rev 2004;8:119–32
- Claliw DJ. The pathogenesis of chronic pain and fatigue syndromes, with special reference to fibromyalgia. Med Hypotheses 1995;44:369–78
- Mahdi AA, Fatima G. A quest for better understanding of biochemical changes in fibromyalgia syndrome. Indian J Clin Biochem 2014;29:1–2
- Ribeiro LS, Proietti FA. Interrelations between fibromyalgia, thyroid autoantibodies, and depression. J Rheumatol 2004;31:2036–40
- Neeck G, Riedel W. Thyroid function in patients with fibromyalgia syndrome. J Rheumatol 1992;19:1120–2
- El Maghraoui A, Tellal S, Achemlal L, et al. Bone turnover and hormonal perturbations in patients with fibromyalgia. Clin Exp Rheumatol 2006;24:428
- Ferrari R, Russell AS. Prevalence of primary hyperparathyroidism in a referred sample of fibromyalgia patients. Clin Rheumatol 2015;34:1279–83
- Russell IJ, Vaeroy H, Javors M, Nyberg F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992;35:550–6
- Häuser W, Urrútia G, Tort S, et al. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome. Cochrane Database Syst Rev 2013;(1):CD010292
- Häuser W, Wolfe F, Tölle T, et al. The role of antidepressants in the management of fibromyalgia syndrome. CNS Drugs 2012;26:297–307
- Badawy AAB. Tryptophan metabolism, disposition and utilization in pregnancy. Biosci Rep 2015;35:e00261
- Badawy AA. The tryptophan utilization concept in pregnancy. Obstet Gynecol Sci 2014;57:249–59
- Arnold LM, Hudson JI, Keck PE, et al. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 2006;67:1219–25
- Glass JM. Fibromyalgia and cognition. J Clin Psychiatry 2007;69:20–4
- Consoli G, Marazziti D, Ciapparelli A, et al. The impact of mood, anxiety, and sleep disorders on fibromyalgia. Compr Psychiatry 2012;53:962–7
- Thieme K, Turk DC, Flor H. Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosom Med 2004;66:837–44
- Fietta P, Manganelli P. Fibromyalgia and psychiatric disorders. Acta Biomed 2007;78:88–95
- Faisal-Cury A, Menezes PR. Prevalence of anxiety and depression during pregnancy in a private setting sample. Arch Womens Ment Health 2007;10:25–32
- Heron J, O'Connor TG, Evans J, ALSPAC Study Team, et al. The course of anxiety and depression through pregnancy and the postpartum in a community sample. J Affect Disorder 2004;80:65–73
- Evans J, Heron J, Francomb H, et al. Cohort study of depressed mood during pregnancy and after childbirth. BMJ 2001;323:257–60
- Holcomb WL Jr, Stone LS, Lustman PJ, et al. Screening for depression in pregnancy: characteristics of the Beck Depression Inventory. Obstet Gynecol 1996;88:1021–5